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Resolving whether inhalation 
of depleted uranium contributed 
to Gulf War Illness using 
high‑sensitivity mass spectrometry
Randall R. Parrish1* & Robert W. Haley2
Of the hypothesized causes of Gulf War Illness (GWI), a chronic multi‑symptom illness afflicting 
approximately 25% of military personnel deployed to the 1991 Gulf War, exposure to depleted 
uranium (DU) munitions has attracted international concern. Past research has not tested the 
potential association of GWI with inhaled DU nor used isotope mass spectrometry of sufficient 
sensitivity to rigorously assess prior DU exposure. We applied a standard biokinetic model to predict 
the urinary concentration and uranium isotopic ratios for a range of inhalation exposures. We then 
applied sensitive mass spectrometry capable of detecting the predicted urinary DU to 154 individuals 
of a population‑representative sample of U.S. veterans in whom GWI had been determined by 
standard case definitions and DU inhalation exposures obtained by medical history. We found no 
difference in the 238U/235U ratio in veterans meeting the standard case definitions of GWI versus control 
veterans, no differences by levels of DU inhalation exposure, and no 236U associated with DU was 
detected. These findings show that even the highest likely levels of DU inhalation played no role in the 
development of GWI, leaving exposure to aerosolized organophosphate compounds (pesticides and 
sarin nerve agent) as the most likely cause(s) of GWI.
Thirty years have passed since the 1990 invasion of Kuwait by Iraq and the subsequent 1991 Persian Gulf War 
that liberated Kuwait. During or shortly after the 1991 conflict, an estimated 25%1 of the approximately 700,000 
deployed U.S. (and additional allied) military personnel developed an unusual chronic multi-symptom illness, 
referred to as Gulf War Illness (GWI)2, manifested by fatigue, fever and night sweats, memory and concentra-
tion problems, pathogen-free diarrhoea, sexual dysfunction, chronic body pain and other symptoms compatible 
with autonomic nervous system  dysfunction3 and dysfunction of the brain’s cholinergic  system4. Investigations 
into the causes have considered potential war theatre exposures including low-level chemical warfare nerve 
agent(s), pyridostigmine bromide anti-nerve-agent medication, pesticides, multiple immunizations, depleted 
uranium (DU), and combat stress. The possibility of toxic effects from DU, first raised after the first large scale 
use of DU munitions in the Gulf War, have stimulated international concern because of potential exposure of 
civilian populations from the Gulf War and from later conflicts in Kosovo, Bosnia, the Persian Gulf and oth-
ers. Studies attempting to address this concern have failed to generate a consensus because of limitations in the 
sensitivity of tests for DU in urine and the lack of any investigation of DU in veterans meeting accepted case 
definitions of GWI.
DU is uranium depleted isotopically in the more fissile 235U isotope which is separated by isotope enrich-
ment methods to produce enriched 235U for use in nuclear reactors and nuclear weapons. Instead of remaining 
as unused nuclear waste, it has been made into dense armour-piercing munitions used in military conflicts in 
1991 and 2003 onwards as well as in tank armour. In a hard target impact a DU-containing projectile efficiently 
penetrates the target’s armour, partially fragments the DU core, and ignites a brief intense fire, combusting 
and oxidizing DU into aerosolized oxides. Humans may then internalize DU by inhalation of aerosolized DU 
oxides, oral ingestion of DU oxide particles that settle in the environment, or retention of DU in metallic form 
in shrapnel fragments in body wounds.
Adverse effects of significant intake are hypothesized to result from heavy metal toxicity and alpha particle 
radiation from DU mainly in the lungs, kidneys and bone where it is concentrated. Despite numerous studies 
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demonstrating long-term urinary excretion of DU from industrial exposure and prediction of possible adverse 
effects on the basis of doses of heavy metal and alpha  radiation5–8, no actual adverse effects in humans have been 
described, though serious effects may be masked because of major gaps in  research9. Nevertheless, DU continues 
to be considered a plausible cause of  GWI10 and courts in the UK and Italy have attributed illness and death to 
inhalation exposure to  DU11,12.
The 1991 Gulf War presents an opportunity to study the health effects of inhaled DU. Approximately 300 
tonnes of DU-munitions were fired by tanks, artillery and aircraft mainly at targets in southern Iraq and espe-
cially along the Basra Road where Iraqi tanks were destroyed in large numbers by DU munitions. In addition to 
combat-related exposures, in July 1991 a post-war explosion and fire at an ammunition storage site within U.S. 
Army Camp Doha, Kuwait, resulted in a series of explosions involving several tonnes of DU munitions, causing 
DU-related aerosols to be released into the dense smoke plume from the fire to which many personnel were 
exposed during containment and clean-up13.
Natural uranium (NU) is composed of 238U (99.27%), 235U (0.72%) and 234U (0.0054% in minerals, 
0.005–0.02% in water sources), with a 238U/235U ratio of 137.80–137.881,14. In the production of nuclear fuel, 
enriched uranium (EU) high in 235U is extracted from NU leaving the residual DU strongly depleted in 235U 
and thus with a greatly increased 238U/235U ratio of approximately  5008,15. Aside from fission of 235U in power 
generation, nuclear reactions also include neutron capture by 235U generating 236U, which is absent in NU; when 
re-enriched during nuclear fuel recycling, the resulting DU acquires this rare isotope. While EU has variable and 
significant amounts of 236U, DU contains 236U in low proportions (~ 0.003%)15. The large differences in isotope 
composition among EU, NU and DU can be exploited by mass spectrometry to quantify even small proportions 
of DU in humans and the  environment16,17.
NU occurs naturally in food, water and soil. A portion (~ 2%) of ingested or inhaled uranium is absorbed into 
the bloodstream, concentrated and stored in bone and kidney, and excreted slowly in urine over many years. A 
large intake of NU, EU or DU can usually be detected by a urine assay for total uranium concentration [U]. Total 
[U] values above 43 ng/g of creatinine—the 95th percentile of the US  population18,19—indicate an excess body 
load of uranium, but highly sensitive mass spectrometry is required to determine whether the excess is due to 
NU, EU, DU or some combination. Two methods of mass spectrometry have been used to detect DU in human 
urine samples: lower precision sector-field mass spectrometry (SF-ICP-MS) has been used to differentiate DU 
from NU in Gulf War veterans at 238U/235U ratios above 166; whereas, higher precision multi-collector mass 
spectrometry (MC-ICP-MS) applied to chemically purified U can detect DU at 238U/235U ratios as low as 140.
A series of studies between 1993 and 2009 was conducted to determine whether an exposure to DU in the 
1991 Gulf War resulted in enough absorption to detect in urine years  later5. At first, small numbers of U.S. soldiers 
who had been involved in friendly fire explosions and, later, U.S. veterans who wanted to be tested provided 
urine samples for assay. All of the studies attempted to identify DU by measuring the total [U]. Some, but not 
all, veterans with X-ray-documented DU fragments retained in their bodies were found to have extremely high 
total [U] levels, far above the 95th percentile of the U.S. population—the cut point for distinguishing DU—and 
no veterans with inhalation exposures but no retained shrapnel did. In recent  studies20,21, however, measure-
ments with low precision SF-ICP-MS identified 3 veterans out of 1,700 with 238U/235U ratio above the cut point 
of 166 confirming DU in their urine, but 2 of these 3 had total [U] below the cut point for DU and the third was 
right at the cut point; whereas, 29 veterans with no evidence of DU by SF-ICP-MS were nevertheless above the 
cut point by total [U], and other veterans who recalled inhalation exposures had far lower total [U] levels. Thus, 
while these studies demonstrated that a few veterans with retained shrapnel excrete very high levels of DU in 
their urine, the method was too imprecise to evaluate excretion from inhalation exposures. More importantly, 
since none of the studies measured the veterans’ continuing symptoms or applied the standard GWI case defini-
tions, no study has yet addressed the question of whether the symptoms of GWI could be due to DU exposure.
In this paper we extend prior work to measurement of DU excretion in U.S. veterans with or without GWI 
who reported information on possible DU exposures. We first calculated the urinary DU concentrations expected 
as a function of time since exposure to plausible DU oxide levels from aerosol inhalation scenarios in the 1991 
Gulf  War6,8,22 based on the Human Respiratory Tract Model (HRTM) relating absorption and  excretion23. We 
then evaluated the capability of the following 3 bioassay methods to detect the subtle DU excretion in urine 
expected from inhalation absorption: (1) screening for excess total [U]; (2) measurement of 238U/235U ratio with 
high sensitivity multi-collector mass spectrometry (MC-ICP-MS) on chemically purified U; and finally, bivariate 
analysis of the 236U/238U and 235U/238U isotopic ratios. We applied these methods to a highly studied population-
representative sample of both theatre-deployed and non-deployed Gulf War-era U.S. veterans in whom Gulf 
War Illness (GWI) had been determined by standard case definitions, whose wartime DU exposures had been 
ascertained by interview, and who provided a 24-h urine sample 18–20 years after the war. We compared these 
measured values to those predicted to be found 18–20 years after exposure to medically meaningful DU levels in 
the war. The goal was to provide the best chance of finding DU if potential disease-causing inhalation exposure 
had occurred and for the first time provide high confidence in a negative finding.
Results
Predicted values of DU excretion from historic inhalation exposures. Inhaled fine particulates of 
DU oxide have the potential to lodge deep in the lung, decompose slowly into solution into the blood stream, 
and become stored in bone, kidney and other organs to be excreted over time with organ and bone re-working, 
all while undergoing slow radioactive decay. The rate of dissolution is a key parameter that underpins the notion 
that DU can be detected in urine many years after exposure.
To test whether DU plays any role in GWI, it is first necessary to predict the concentration of DU expected 
in a urine sample for a given DU aerosol inhalation exposure as a function of the dose and oxide type of the 
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original DU exposure, the time since exposure, and likely dietary intakes of NU in the run up to urine collection. 
Without this prediction, it is impossible to know whether a negative test is due to an inconsequential exposure 
or an insensitive urine assay method—a valid criticism of past research on this problem.
The defining studies by the U.S. Department of  Defense6, the World Health  Organisation22 and the British 
Royal  Society8, classified battlefield situations of potential DU aerosol exposure into 3 standard exposure levels 
likely to occur in combat situations: level I-high, level II-medium, and level III-low. Exposure level I includes 
direct inhalation of an impact aerosol; level II, inhalation of resuspended impact aerosol or oral ingestion within 
a contaminated vehicle; and level III, inhalation of an aerosol plume at a distance from an impact or fire or 
resuspension from ground contamination. Doses in milligrams of DU taken into the body in each of these situ-
ations were estimated with evidence from other studies, including field studies involving measurements during 
destruction of vehicles with DU penetrators (Table 1)6.
We used the modelling  of8,22,24 to estimate the urinary excretion of uranium on the basis of an inhalation dose. 
We considered intake doses representing each of the Royal Society’s exposure levels at 18 years after exposure and 
at 2 likely dietary intake levels of NU in the run up to urine collection to predict current excretion rates of DU 
oxides  (UO2,  U3O8, etc.) in a range of excretion levels determined by the level of uncertainty in the ICRP models 
(Fig. 1). The model  output8,24 allowed calculation of the current expected ranges of the following 3 parameters 
most used for detecting past DU exposure from urinary assays: total [U], the 238U/235U isotopic ratio, and the 
236U/238U ratio, given in Table 1.
Comparison of the ability of three methods to distinguish DU from NU in urine. Total [U]. Ap-
plying the criterion of finding > 50 ng U/g creatinine of total [U] in urine will detect only veterans excreting the 
very highest total [U] in those with Level I inhalation exposures in the Gulf War, but would be unable to distin-
guish any with Level II or III exposures from NU excretion (Table 1).
238U/235U measured by SF‑ICP‑MS. The relatively low precision SF-ICP-MS method would be able to differenti-
ate DU from NU in all veterans with Level I exposures in the Gulf War and most in the upper half with Level II 
exposures but only if they are consuming a diet low in NU (average 2 ng NU per day) so that DU is ≥ 25% of the 
total U excreted. It would thus be unable to differentiate most with Level II and all with Level III exposures from 
NU excretion (Table 1).
238U/235U measured by MC‑ICP‑MS after rigorous chemical purification of U (this study). The high precision 
MC-ICP-MS method combined with chemical separation and purification of U from urine, allows the detec-
tion of excreted DU at a rate of > 0.068 ng/day, our methodological DU detection limit. Our prediction model 
indicates that it would detect an initial inhalation exposure of as little as 0.40 mg of DU from the 1991 Gulf War. 
Thus, it would be able to identify DU in all veterans with Gulf War exposures far less than the lowest Level III 
exposure (2 mg DU inhaled during the Gulf War) even if consuming a diet relatively high in NU before urine 
collection (Table 1). It follows then that only mass spectrometry with high precision MC-ICP-MS is capable of 
detecting DU from inhalation exposure in the Gulf War or confirming its absence in most Gulf War veterans.
Table 1.  Current ranges of urinary total [U] and U isotopic ratios that identify DU estimated from different 
levels of DU inhalation exposure during the 1991 Gulf War, time since exposure, and daily dietary intake 
of natural uranium running up to urine sample collection. a Numerical values are derived from calculations 
 of8,23,24 as illustrated in Fig. 1, described in more detail in on-line methods. b In the most recent study of DU in 
Gulf War veterans, Dorsey et al.20 screened urine total [U] for DU by this criterion. c Dorsey et al.20 identified 
the presence of DU with the 238U/235U ratio measured by lower precision sector field–inductively coupled 
plasma-mass spectrometry (SF-ICP-MS). d The present study identified the presence of DU with the 238U/235U 
ratio measured by the high precision multiple collector–inductively coupled plasma-mass spectrometry 
(MC-ICP-MS).
Parameters specified in the prediction model
Ranges of parameters expected 18 years after 
specified DU inhalation exposure





intake (mg) for the 
exposure level in 
1991 Gulf  Wara
Daily dietary U 
excretion (ng) in 
run-up to testing
Total [U] (ng U/g 
creatinine) 238U/235U 236U/238U × 10–6
Method 1: total 
[U] > 50 ng U/g 
 creatinineb
Method 2: 
238U/235U > 166 by 
SF-ICP-MSc
Method 3: 
238U/235U > 140 by 
MC-ICP-MSd
Level I 250
2 14.5–74.5 367–467 25.9–29.2 Rarely Yes Yes
8 20.5–80.5 247–397 18.3–27.0 Rarely Yes Yes
Level II 10
2 2.5–4.9 161–241 6.0–17.8 No Yes Yes
8 8.5–10.9 144–171 1.8–8.0 No No Yes
Level II 5
2 2.3–3.5 150–198 3.3–12.6 No No Yes
8 8.3–9.5 141–155 0.9 -4.6 No No Yes
Level III 2
2 2.1–2.6 143–165 1.4–6.7 No No Yes
8 8.1–8.6 139–145 0.4–2.0 No No Yes
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Cohort of GWI cases and controls and battlefield deployment. We measured the uranium isotope 
composition in urine samples from a nested case–control sample of Gulf War veterans selected in a 3-stage strat-
ified random sample of the 1991 U.S. military population studied in the U.S. Military Health Survey (USMHS). 
The methods of sample selection at the 3 stages have been  published3,25. The first stage involved a computer-
assisted telephone interview (CATI) survey (N = 8020) which included questions covering battlefield situations 
likely to involve inhalation of various levels of DU, from which we assigned the standard DU exposure levels. 
The second stage involved blood collection from all veterans whose symptoms met the 3 widely used case defi-
nitions of GWI (cases) and an approximately 15% random sample of those not meeting it (controls), including 
both deployed and not deployed to the Kuwaiti Theatre of Operations. The third stage constituted a smaller 
representative sample selected from the larger stage 2 sample, and included 106 who met the 3 standard case 
definitions of  GWI2,26,27 in which cases comprised of 31 with syndrome variant 1 (“impaired cognition”); 42 with 
syndrome variant 2 (“confusion-ataxia”); 33 with syndrome variant 3 (“central pain”)2; and 47 control veterans 
comprised of 26 deployed to the war theatre and 21 non-deployed not meeting the case definitions. Between 
November 2008 and June 2010, the 154 veterans in the stage 3 sample were studied extensively in a 7-day clinical 
research protocol in which each travelled to Dallas, Texas (USA) to be hospitalized in the University of Texas 
Southwestern Medical Center’s Clinical and Translational Research Center. In addition to diverse neuropsycho-
logical, autonomic and neuroimaging studies, a 24-h urine sample was collected in urine containers prewashed 
with nitric acid to remove any trace uranium; creatinine was measured on an aliquot shortly after collection.
Effectiveness of total [U] of urine to rule out past DU exposure. The first method we used to detect 
evidence of past DU exposure was to screen the 154 GWI cases and control subjects’ urine for an increase in 
total [U] excretion (Table 2). The distribution of total [U] was similar to that of the U.S.  population19, and no 
values exceeded its  95th percentile (Fig. 2a). The geometric mean of total [U] of the cases meeting the 3 case 
definitions of GWI was 1.78 ng U/g creatinine, statistically indistinguishable from the combined deployed and 
non-deployed controls (geometric mean 1.57 ng U/g creatinine, t test P = 0.18). These values of total [U] are con-
sistent with lack of DU contamination but do not exclude the possibility of the small amounts of DU expected 
from our prediction model with Level II and III inhalation exposures (Table 1). Although continuing dissolution 
of DU shrapnel in metallic form retained in the body usually increases total [U] beyond the population’s 95% 
percentile, as concluded  by20, our findings further confirm that screening of total [U] is not useful for detecting 
the far smaller intake doses and the time-limited exposure situations involved in inhalation exposures to DU 
aerosols (Table 1).
Use of high precision 238U/235U to determine significant inhalation exposure. The second method 
we used to detect past DU exposure was analysis of the 238U/235U isotopic ratio measured by the high precision 
MC-ICP-MS method (Table 3). The uncertainty in the 238U/235U ratio, measured by its 95% confidence interval, 
increases (precision decreases) as the urinary total [U] decreases (Fig. 2b), but it was less than ± 1% for 95% of 
the samples (Fig. 2b). For urine samples with total [U] above 1 ng/g creatinine and a ± 1% uncertainty, values of 
Figure 1.  Estimation of current urinary DU excretion from DU oxides absorbed 18 years earlier. From the 
Human Respiratory Track Model (HRTM) for inhalation of uranium oxides we estimated the daily urinary 
excretion of DU, expressed as a fraction of the original inhaled dose (log scale), and plotted as a function of days 
since inhalation (log scale). In the sample of veterans studied, the duration between potential inhalation (in the 
first half of 1991 during the conflict) and the urine collection (November 2008–June 2010) was 6720 ± 365 days 
or 18.4 ± 1.0 years, shown as the width of the small red box. The analogous region from Dorsey et al.20 discussed 
in the text is shown in the larger blue box. Three curves showing fractional uranium excretion predicted by the 
combined dissolution-storage-excretion function of the HRTM for uranium oxide particulates are shown; these 
represent “Low” and “High” absorption curves during dissolution and metabolism of compounds of uranium 
oxide with contrasting chemical form and solubilities. The figure is modified  from8,24 using the HRTM model 
with aerosol and oxide physicochemical characteristics  summarized8 and taking into account the uncertainty in 
the HRTM model  parameters23.
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the 238U/235U ratio above 139–140 including their lower uncertainty bound are considered likely to represent the 
presence of DU (Fig. 2b). This threshold of 139–140 for confirmation of DU is more robust and > 10 times more 
sensitive than the threshold of 166 applied by Dorsey et al. using the lower precision SF-ICP-MS (Table 1)20.
Exposure situations. When predictions of DU excretion are applied to groups of veterans with different stand-
ard levels of DU inhalation exposures, the 238U/235U ratios are below 139 for veterans with all 3 inhalation 
exposure levels (Fig. 2c; Kruskal–Wallis test P = 0.74). The 3 veterans with outlying values nearest the threshold 
between 139 and 140 all had very low values of total [U] and thus very wide uncertainty intervals that gener-
ously overlap the 238U/235U of NU (~ 137.8). When the battlefield exposure situations from which the standard 
exposure levels were generated were broken out, the distributions of the 238U/235U ratios showed no pattern sug-
gesting any departure from NU outside of methodological uncertainty (Fig. 2d).
GWI symptoms. Likewise, veterans who continue to have potentially disabling symptoms of GWI had distribu-
tions of the 238U/235U ratio that did not differ from the deployed and non-deployed control veterans (Fig. 2e), and 
none had values that differed from NU. Moreover, the distribution of the 238U/235U ratios in the 3 GWI syndrome 
variant groups combined was similar to those of the deployed and non-deployed control groups (Kruskal–Wallis 
test P = 0.16).
Bivariate analysis of the 236U/238U and 235U/238U as a further test of DU exposure. As a further 
test for the possibility of DU in these veterans, we studied their location on the bivariate distribution of the vet-
erans’ ratios of both 236U/238U and 235U/238U isotopic ratios. This is an important procedure because, since 236U is 
found only in EU and DU but not in NU, it provides a further direct method of distinguishing DU from NU and 
from ascertaining whether EU may also have been involved. Since 236U constitutes only ~ 0.003% of DU used in 
munitions, it can only be measured by high precision MC-ICP-MS and thus has not previously been measured 
in research on GWI.
We applied this approach to our representative sample of Gulf War veterans in the context of prior  studies7,15,28 
of groups of U.S. civilians exposed to DU (and EU) aerosol pollution in New York State from a uranium fab-
rication plant in the 1960s and  1970s29 and in part studied with MC-ICP-MS of urine samples using the same 
methods as in our  study7. These studies demonstrated that significant doses of DU aerosols inhaled by factory 
workers and residents living nearby can be detected in urine ≥ 25 years after the plant was  closed7,28, broadly 
consistent with predictions of the HRTM model.
In the bivariate plot in Fig. 2f, an individual excreting pure NU would be located at the point where 
235U/238U = 0.00726 and 236U/238U = 0, reflecting the usual amount of 235U and the absence of 236U in natural U. A 
theoretical individual excreting pure DU would be located at a point defined by 235U/238U ≈ 0.002 and 236U/238U ≈ 
0.00003, but most DU-exposed workers excrete a combination of DU and NU, which displaces them downward 
and to the right; whereas, EU added to the mix would displace them upward and to the right. Using published 
analyses of workers from the plant, mixtures of NU and DU had lower 235U and higher 236U, locating them along 
the solid line. Mixtures of NU and EU would have 235U/238U above that of NU (235U/238U > 0.00726), indicating 
substantially increased 235U, and variably increased 236U. Mixtures of NU, DU and EU would appear along the 
dashed line in the diagram.
Published studies of the DU plant workers and local town residents with proven non-military DU aerosol 
 exposure7,28 are shown to illustrate where subjects with proven inhalation exposure to DU typically fall. All but 
6 of the Gulf War veterans in our study are located in a narrow zone located exactly at 235U/238U = 0.00726, the 
value of natural U, and with 236U/238U ratios within the uncertainty zone around 236U/238U = 0 (Fig. 2f). The 6 
exceptions have slightly elevated 236U/238U ratios and values of the 235U/238U incompatible with both DU and EU, 
indicating an artefact of measurement from organic molecule interference in these samples (see explanation in 
Supplemental materials, mass spectrometry).
Table 2.  Urinary excretion rate of total U by Gulf War veterans’ clinical group.





Mean 95% CI 5th and 95th percentile Range Median Mean
Non-deployed controls 21 2.37 − 1.04/+ 1.86 0.24–11.2 0.2–30.2 1.25 1.24
Deployed controls 27 3.80 − 1.60/+ 2.78 0.42–50.2 0.32–96.4 2.16 1.87
GWI syndrome 1 31 2.53 − 0.78/+ 1.12 0.58–10.7 0.22–13.3 1.38 1.41
GWI syndrome 2 42 4.00 − 1.25/+ 1.81 0.77–21.7 0.70–28.8 2.05 2.15
GWI syndrome 3 33 3.33 − 1.05/+ 1.54 0.65–12.0 0.44–15.1 1.95 1.74
All controls 49 2.98 − 0.98/+ 1.45 0.36–25.9 0.17–96.4 1.86 1.57
All GWI 106 3.30 − 0.57/+ 0.69 0.69–16.2 0.13–23.9 1.84 1.78
All samples 154 3.24 − 0.56/+ 0.68 0.57–17.6 0.17–96.4 1.84 1.71
6
Vol:.(1234567890)




Scientific Reports |         (2021) 11:3218  | https://doi.org/10.1038/s41598-021-82535-3
www.nature.com/scientificreports/
Veteran with a Level I battlefield exposure and DU shrapnel wound. One Gulf War veteran in 
our study was standing on an Abrams tank when it was hit in a “friendly fire” accident by a DU round which 
destroyed the tank, threw the individual several meters, peppered him with a mix of sand, pebbles and shrapnel, 
tattooing his skin and embedding 2 pea-sized pieces of DU shrapnel under his skin. He breathed the hot gases 
from the explosion for several minutes. Upon return to his base in the U.S. 4 months later, the shrapnel was 
removed. During his wartime deployment to the war theatre, however, he was also exposed to low-level sarin 
nerve agent, took pyridostigmine tablets, and has moderately low PON1 type Q isoenzyme level, which are 
typical risk factors for  GWI30–32. The veteran had symptoms satisfying the case definitions of GWI, subclassi-
fied as variant syndrome 1 (“cognitive impairment”), but his urine showed a total [U] of 1.35 ng/g creatinine, a 
238U/235U ratio of 137.8, and a 236U/238U ratio below detection limit (< 0.000001)—all typical of natural U with no 
DU. If residual DU were present it was being excreted at a rate of < 0.068 ng/day, our limit of detection, and our 
prediction model indicates that he could have absorbed no more than 0.40 mg of DU from the Gulf War from 
both inhalation and DU shrapnel.
Discussion
Our findings, using high precision mass spectrometry MC-ICP-MS on chemically purified U that detects even 
the lowest level of DU exposure capable of causing illness, demonstrate that a sample of veterans drawn from a 
large population-representative sample of Gulf War veterans, meeting the case definitions of GWI and reporting 
a range of inhalation exposures to DU in friendly fire accidents, did not absorb even the smallest amount of DU 
capable of producing chronic adverse effects on health. The past studies of DU in Gulf War veterans have shown 
clear evidence of DU absorption into the body only in individuals with chunks of DU in metallic form as shrapnel 
retained in tissues from friendly fire wounds. The methods of detecting DU used in those studies—total [U] and 
limited use of U isotope ratios measured by the less precise SF-ICP-MS mass spectroscopy method—however, 
had insufficient precision to differentiate the lower levels of DU absorption likely with inhalation exposures from 
dietary NU absorption. Moreover, no past study has tested the association of urinary DU excretion measurements 
with GWI defined by the standard case definitions. Consequently, past studies did not address the question more 
widely concerning to Gulf War veterans and others of whether inhalation of DU in the war caused, or contributed 
to, the GWI. Our study, however, found no DU excretion in either veterans meeting the case definitions of GWI 
or control veterans not meeting them. Given the high precision of our methods, our results not only show an 
absence of evidence for an association but evidence for the absence of that association.
The element of our study design that gives meaning to a negative finding is that we first developed estimates 
of the amount of DU that would still be excreted in urine 18 years after exposure to amounts of DU found 
through simulation studies to result from various situations where soldiers inhaled DU oxides from explosions 
of DU munitions. We then tested urine from a representative sample of ill and well Gulf War veterans with the 
high precision mass spectrometry method, not used in prior testing of large samples of veterans, that is capable 
of detecting the levels of DU excretion predicted by the model. We based the predictions on the best estimates 
of the bodily absorption of DU that results from various exposure events and the modelling on the most widely 
accepted approach of the International Commission on Radiological Protection’s (ICRP) Human Respiratory 
Tract  Model8,23,24. This study design provided the best chance of finding evidence of DU exposure if it exists but 
also provides a high degree of confidence in a negative finding as well.
A limitation of our study is that we included only Gulf War-era veterans who were potentially exposed to 
inhalation of DU from infrequent, very brief, though often intense, friendly fire accidents and sporadic inha-
lation of dust potentially contaminated with DU particulates over a 4–5 month period. While study of these 
Gulf War veterans addresses the question of whether short-term and potentially intense inhalation exposures 
produce enough systemic absorption to cause chronic illness, it may not adequately address the wider implica-
tions of decades of continuous exposure to DU-containing dust faced by the populations in war zones where 
Figure 2.  Exposure levels, incidents, and GWI clinical classification. (a) Total [U] (ng/g of creatinine) by 
veterans’ GWI clinical classification; horizontal lines indicate the 50th, 75th and 95th percentiles of the 
distribution of urine U concentrations in the US  population18,19 and the lower limit for detecting DU  of20. (b) 
Veterans’ 238U/235U ratios with individual measurement uncertainty intervals by total [U], demonstrating how 
the uncertainty intervals and variance increase at lower total [U]. All certainty intervals overlap natural U 
(horizontal lines). (c–e) Distributions of veterans’ 238U/235U ratios by standard classification of DU exposure 
 levels8, (c) by specific DU exposure situations (d), and by GWI clinical classification (e). The horizontal 
reference lines indicate the range of the 238U/235U ratio of natural U (137.80–137.88), above which values suggest 
mixtures of natural U and DU and below which, mixtures of natural and enriched U; individual measurement 
uncertainties of ~ 1% are omitted for clarity. (f) Bivariate scatterplot of 236U/238U ratio by 235U/238U ratio for the 
sample of Gulf War veterans (red symbols), overlaid by those of workers in a DU plant in the town of Colonie, 
New York, known to have had substantial occupational inhalation DU  exposures7,28. The horizontal reference 
line at 236U/238U = 0 emphasizes that natural U contains no 236U. The ratios from subjects with various exposure 
levels of DU would fall along the solid line; whereas, subjects with mixed exposure to DU and enriched U would 
fall in the upper right where one such DU worker is shown. Six of the Gulf War veterans had elevated 236U/238U 
ratios with certainty intervals that do not overlap zero, but their 235U/238U ratios are not reduced, which is 
incompatible with DU and EU; this is caused by an isobaric interference on mass 236 and is explained in the 
online methods and the text. The standard DU exposure levels range from level III (lowest) to level I (highest)8 
The GWI clinical classification includes syndrome 1 (impaired cognition), syndrome 2 (confusion-ataxia) and 
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DU munitions have been deployed. The design of our study applying high precision mass spectroscopy to urine 
samples could readily be adapted to study residents of former war zones to identify ongoing DU excretion as a 
quantitative biomarker of true DU absorption. Any effects of this exposure on health could then be addressed 
with clinical studies comparing sensitive measures of adverse health effects in persons with DU-positive and 
DU-negative test results.
For now, however, Gulf War veterans need no longer be concerned that a connection between their chronic 
illnesses and DU exposure in the Gulf War has been inadequately addressed by insensitive methods of measuring 
DU excretion and studies not relating DU measurements directly to GWI. If DU had been an important cause of 
GWI, our study, applying the most precise measure of DU to a representative sample of Gulf War veterans meet-
ing the standard case definitions, was sensitive enough to have found it. From our negative results, we conclude 
that inhalation of DU during the Gulf War was not an important contributor to the GWI. Now scientific atten-
tion must be focused even more intensely on the remaining likely causes, particularly the widespread exposure 
to cholinesterase-inhibiting toxicants including low-level sarin nerve gas known to have been widely dispersed 
during destruction of chemical weapons stores by Allied bombing of Iraqi chemical weapons storage  depots32,33, 
as well as pesticides and pyridostigmine, for which considerable evidence  exists31.
Methods
Subjects. The 154 Gulf War-era U.S. military veterans who participated in this study were selected by a 
3-stage statistical sampling plan as a representative sample of those who served in the U.S. armed forces during 
the 1991 Persian Gulf War, the target population. The first stage involved a computer-assisted telephone inter-
view (CATI) survey of a stratified random sample of the target population, known as the U.S. Military Health 
Survey (USMHS). The sample was selected from the computer personnel file of the Gulf War-era military popu-
lation between August 2, 1990 and July 1, 1991, obtained from the Defense Manpower Data Center (DMDC, 
Seaside, CA), stratified by the following design parameters: a flag indicating deployment to the Kuwaiti Theatre 
of Operations (KTO), age (< 49 years, ≥ 49 years), sex, race/ethnicity (non-Hispanic white, other), military rank 
during the war (officer, enlisted), military component (active duty, Reserve/Guard), military occupation (air 
flight crew, aircraft maintenance, army special operations, other), location in KTO on 20 January 1991 (deployed 
only), and 3 special study samples (twin pairs, member of 24th Reserve Naval Mobile Construction Battalion, 
and parent of a child with Goldenhar complex birth defect). Of the full USMHS sample (n = 8020), 6497 were 
deployed to the KTO, and 1523 were non-deployed. With 74.9% of the selected veterans located and contacted 
and 80.2% of these agreeing to participate, the overall response rate was 60.1%. The methods, extensive pilot 
testing and initial findings of the USMHS were described in detail  elsewhere25.
The standardized interview included questions on specific in-theatre scenarios previously defined by the U.S. 
Army’s DU Capstone project for calculating the 4 levels of DU exposure recommended for epidemiologic studies 
 by6,8. It also contained all questions required to define the 3 most often used case definitions of GWI: the  Factor2, 
 CDC26, and Modified  Kansas27 definitions. The Factor case definition was developed with principal components 
analysis of symptom scales to identify groups of veterans with similar patterns related to deployment and was 
Table 3.  Urinary uranium isotope ratios by Gulf War veterans’ clinical group. DU depleted uranium, IRMM 
European Commission’s Institute for Reference Materials and Measurements, LOD limit of detection, n/a not 
applicable, U uranium. a Geometric means with 95% CI. b Since 238U/235U uncertainties are not significantly 
asymmetrical and are reported as a single value. c The 236U/238U ratios were overwhelmingly below the 
0.0000015 limit of detection after all corrections and uncertainty propagations were made. d The 4 analyses of 
in-house urine that had no additional IRMM184 added. e IRMM184+ 233U values reported are corrected for 
very minor contributions of other isotopes in the 233U that was added. f IRMM certified value from https ://crm.
jrc.ec.europ a.eu/p/40454 /40475 /By-appli catio n-field /Nucle ar/IRMM-184-URANI UM-238-NATUR AL-ISOTO 
PIC-NITRA TE-SOLUT ION/IRMM-184.
Clinical group Sample size
238U/235U 236U/238U
Median Meana 95%  CIa Meana,c 95%  CIa
Undeployed controls 21 137.79 137.62 0.26  < LOD n/a
Deployed controls 27 137.84 137.75 0.25  < LOD n/a
GWI syndrome 1 31 137.50 137.51 0.16  < LOD n/a
GWI syndrome 2 42 137.62 137.68 0.16  < LOD n/a
GWI syndrome 3 33 137.62 137.71 0.19  < LOD n/a
All controls 49 137.79 137.70 0.18  < LOD n/a
All GWI 106 137.55 137.64 0.10  < LOD n/a
All samples 154 137.63 137.66 0.09  < LOD n/a
In house urine no  IRMM184d 4 137.70 137.68 0.27  < LOD n/a
2 ppb IRMM184 + 233Ue 125 137.70 137.71 0.05 1.11E−07 1.3E−08
IRMM184  certifiedf 137.70 0.04 1.25E−07 5.3E−10
Natural uranium 137.82  ~ 0.06  < 10–8 n/a
DU in munitions  ~ 500  ~ 0.000030
9
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extensively  validated25,34. All deployed personnel were present for the 5-week air war and the 5-day ground war 
in January and early February 1991.
The second stage involved selection of all veterans who met any of the 3 case definitions and an approximately 
15% random sample of all who did not. The resulting sample included 2103 veterans, from whom samples of 
peripheral blood serum, plasma, DNA and RNA were collected by trained phlebotomists in or near subjects’ 
homes, shipped overnight to the UT Southwestern laboratory, and archived for later studies.
The third stage selected a subset (n = 154) of those who participated in the second stage and were randomly 
selected as a representative sample of Gulf War-era veterans with and without GWI. These were hospitalized 
between late 2008 and June 2010 in the UT Southwestern Medical Center’s Clinical and Translational Research 
Center for a 7-day research protocol involving 25 clinical neurological, neuroimaging, EEG and genetic studies 
of GWI. This protocol included the collection of a 24-h timed urine collection supervised and timed by profes-
sional research nurses in the hospital’s clinical research center. The urine samples were collected in urine col-
lection bottles that had been pre-washed with an HCL solution to remove any trace of uranium. Urine samples 
thus post-date potential DU exposure by approximately 18 years. At the completion of collection, the volume of 
each 24 h urine sample was measured and recorded, and an aliquot was sent to Quest Laboratories for creatinine 
determination. The urine samples were then stored at 4 °C. In late 2017, a 500 ml aliquot was taken from each 
well shaken urine sample, and sent to the University of Portsmouth in the U.K. for uranium isotope analysis 
with generic sample numbers for blind analysis. All participants gave written informed consent according to a 
protocol approved by the institutional review board of the University of Texas Southwestern Medical Center and 
methods followed relevant guidelines and regulations.
Calculation of inhalation exposure and excretion of inhaled uranium. The predictions of uri-
nary DU concentrations from DU absorbed 18 years earlier, shown in Fig. 1, are based on information in the 
annexes to the comprehensive study by the Royal Society report on DU [annexes C, G, H of 8; 22,24]. These 
sources describe the absorption of inhaled material from the respiratory tract and how this can be modelled 
in terms of accumulation in kidney and bone and excretion in urine over time, dependent upon the type and 
solubility of uranium oxide particles. These are based upon the Human Respiratory Tract Model (HRTM) of 
the International Commission on Radiological  Protection23  and8, the latter providing available information on 
absorption characteristics (i.e. lung solubility) of particulate DU from DU penetrator impact and combustion in 
fires. Because relatively insoluble  UO2 and  U3O8 are the predominant oxides from  DU6,35, they have the slowest 
dissolution rate constants, approximately 0.0012–0.00035 and 0.0015–0.00049 for  U3O8 and  UO2, respectively.
The  modelling8,24 using the Human Respiratory Tract  Model23 is shown in Fig. 1 for inhalation of U oxides of 
various types and illustrates daily excretion as a fraction of the original intake as a function of time. The red box 
of Fig. 1 uses 18.4 ± 1.0 years as the duration between inhalation and urine collection, and the fractional excretion 
of inhaled DU is 1.7 ± 1.2 × 10–7. An analogous blue box is shown for the Dorsey et al.  study20. Using a range of 
initial inhalation doses of DU from 250 down to 2 mg, we calculated the DU excretion during the time window 
of urine collection and added two contrasting ranges of daily dietary excretion of natural U of 2 and 8 ng/day 
of U. For these calculations the 238U/235U and 236U/238U for DU were 500 and 30 × 10–6, and for natural U 137.82 
and 0, respectively. From these excretion rates, we calculated (Supplemental Material, indicative calculation) the 
fractional amount of DU in urine, and the corresponding isotope ratios of 238U/235U and 236U/238U; this allows 
assessment of measurement capabilities and limits of detection for DU for our method and that of all previous 
urinary U isotope measurements of US Gulf War  veterans20, which used a less sensitive SF-ICP-MS methodology.
The predicted isotope ratios 238U/235U and 236U/238U were calculated from Eqs. (1) and (2), using end member 
DU of 238U/235U = 500 and 236U/238U = 30 × 10–6, (2) NU 238U/235U = 137.82 and 236U/238U = 0, and the fraction of 
excretion that is DU (fDU).
The sensitivity threshold for positive detection of DU using 238U/235U measurements was 139–140 for our 
method (described below) and 166 according to the methods used  by20. Because we could not detect DU if its 
proportion was < 2%, corresponding to a 238U/235U of 140, we calculate that based on the mean rate of excretion 
of 3.4 ng/day, the maximum amount of DU excreted would be < 0.068 ng/day. Using the HRTM-based calcula-
tion, this leads to a maximum inhalation dose 0.4+1.0/−0.2 mg during the Gulf War.
Chemical and isotope measurement procedures. Samples were measured blind at the University of 
Portsmouth in that they had generic sample numbers without any information as to subject criteria in terms of 
deployed, not deployed, Gulf War Illness positive or negative—information which was confidentially retained at 
the University of Texas Southwestern Medical Center. Upon receipt of samples at the University of Portsmouth, 
weights of samples were measured and stored for subsequent analysis in a restricted access class 100 laboratory. 
The general procedures used to measure the concentration and isotope composition of uranium from urine are 
adapted from prior  publications7,36 and followed methods in accordance with regulations. Particular variations 
to published methods are described below and in the Supplemental Material. The procedure involved a full 
chemical separation and purification of uranium extracted by calcium phosphate co-precipitation from 150 ml 
of urine using pre-cleaned reagents (see Supplemental Material, reagents) in a class-100 clean laboratory and 
multiple collector inductively coupled plasma mass spectrometry (MC-ICP-MS). The study used a Nu Instru-
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certified IRMM184 (Institute of Reference Materials and Measurement, Geel, Belgium) uranium solution almost 
identical with natural uranium to which a high isotopic purity 233U tracer was added (238U/233U ~ 100), repeated 
analysis of an in-house urine to which IRMM184 was partly added, and routine measurement of mass 237 
important for making time-dependent corrections to 236U/238U related to mass abundance sensitivity (down-
mass tailing corrections) arising from pressure variations within the mass spectrometer and trace amounts of 
organic molecular ion interference at masses 236.8 and 235.8 (Supplemental Material, mass spectrometry). The 
method resulted in a LOD on the 236U/238U of 0.000015 or 11 counts/sec on the 236 mass. The uranium intro-
duced during the chemical procedure was 11–38 pg averaging 8–12 pg during each batch. Once all of these cor-
rections were made, the analyses of the IRMM184 reference solution yielded 234U/238U, 235U/238U and 236U/238U 
values of 5.344 × 10–5 ± 2.0 × 10–6, 0.0072614 ± 0.0000025 and 1.1 × 10–7 ± 0.1 × 10–7, respectively, in agreement 
with the certified values. The mean 235U/238U measurement uncertainty and its standard deviation for 154 sam-
ple and 125 IRMM184 measurements was 0.66 ± 0.46% and 0.44 ± 0.19%, respectively, with individual analyses 
available in Supplemental Material Tables S3 and S4.
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